Remission of Type 2 Diabetes with Very Low-Calorie Diets—A Narrative Review
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Very low-calorie diets (VLCD) are hypocaloric dietary regimens of approximately 400–800 kcal/day that result in 20–30% reductions in body weight, sometimes in just 12–16 weeks. A body of evidence demonstrates that adherence to VLCD in adults with type 2 diabetes (T2D) can result in marked improvements to glycemic control and even full T2D remission, challenging the convention that T2D is a lifelong disease. Although these data are promising, the majority of VLCD studies have focused on weight loss and not T2D remission as a primary endpoint. Moreover, there is a wide range of VLCD protocols and definitions of T2D remission used across these hypocaloric studies. Together the large degree of heterogeneity in VLCD studies, and how T2D remission is defined, leave many gaps in knowledge to efficacy and durability of VLCD approaches for T2D remission. This narrative review examines findings from a body of data from VLCD studies that specifically sought to investigate T2D remission, and discusses the efficacy of VLCD compared to other hypocaloric approaches, and who is likely to benefit from VLCD approaches for T2D remission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“VLCDs are very effective at achieving weight loss and significant improvement in cardiometabolic parameters in short periods [221,222], including diabetes remission”
From Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment (2025) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 3×
“The 10-year Q-RISK score, a metric used to assess cardiovascular disease (CVD) risk [43], was reduced from 23% to 7% in responders from the Counterbalance study, which is consistent with a large body of data demonstrating significant reductions in CVD with weight loss and glycemic control in T2D [44,45].”
BackgroundMethodResultGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Although current standard clinical care is effective in maintaining normoglycemia in T2D [3], long-term studies show that intensive glycemic control is not sufficient in halting T2D progression and decline in pancreatic β-cell function, or in mitigating the risk of cardiovascular disease [4,5].”
BackgroundFuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 9×
“DiRECT recruited 306 overweight and obese adults aged 20–65 with a BMI range of 27–45 kg/m, diagnosed with T2D within the past 6 years [22].”
BackgroundMethodResultInfluentialWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 1×
“Evidence suggesting that disease duration and β-cell function are predictors of T2D remission is consistent with the pathophysiology of T2D, in which the onset of pancreatic β-cell loss and secretory insufficiency represent a key clinical transition from insulin resistance to T2D [59].”
ResultReduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Long-term weight-loss maintenance: a meta-analysis of US studies
Anderson, J. W., Konz, E. C., Frederich, R. C., & Wood, C. L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.5.579 · Cited by 1,351 · cited 2×
“The attrition rate for the DiRECT intervention group was 25% at 12 months [22], which is superior to the 25–50% dropout rates in the first 3 to 6 months of prior VLCD studies [27,46,47].”
BackgroundResultBenefits and Risks of Bariatric Surgery in Adults: A Review
Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020) · JAMA · doi:10.1001/jama.2020.12567 · Cited by 1,251 · cited 1×
“Disadvantages of bariatric surgery include the risk of surgical and post-surgical complications, such as wound infection and thromboembolism [68,69], and significant financial burden, with a mean cost of $14,389 in the U.”
BackgroundLim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 11×
“The normalization of FPG to non-diabetic levels after just 7 days occurred with a modest weight loss of approximately 4% of initial body weight, but a 30% decrease in ectopic pancreatic and hepatic triglyceride [17].”
BackgroundMethodResultInfluential
Cited by
Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.04.001 · Cited by 166
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Dhokte, S., & Czaja, K. (2024) · Nutrients · doi:10.3390/nu16071015 · Cited by 133
“Using this connection, researchers have discovered that calorie-deficit diets may be able to control the disease and, in some cases, even put it into remission [33].”
BackgroundInfluentialBays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100108 · Cited by 126
“…and the substantial rate of remission of diabetes mellitus and hypertension that directly correlates to the amount of post operative weight reduction [24,202,246 – 248], with a directionally similar need to adjust anti-diabetes and antihypertension medications with very low-calorie diets [249,250].”
BackgroundThe Role of Glutathione and Its Precursors in Type 2 Diabetes
Tuell, D. S., Ford, G., LOS, E. A., & Stone, W. L. (2024) · Antioxidants · doi:10.3390/antiox13020184 · Cited by 43
Janssen, T. A. H., Van Every, D. W., & Phillips, S. M. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000980 · Cited by 33
“A popular form of VLCD is a very low-calorie ketogenic diet (VLCKD), && VLCKD on glycemic control, body weight, lipid profile, medication use, and dropouts vs. other recommended diets for 12 weeks or longer in people (cid:1) (cid:1) with T2D [43 ].”
BackgroundInfluentialVasdeki, D., Koufakis, T., Tsamos, G., Busetto, L., Zebekakis, P. E., & Kotsa, K. (2022) · Nutrients · doi:10.3390/nu14224801 · Cited by 33
“In general, trials investigating the effectiveness of VLCD in promoting remission present differences in their study design, including the duration of the intervention (8–20 weeks) and the calorie intake (510–853 kcal/day) [51].”
BackgroundTuell, D. S., LOS, E. A., Ford, G. A., & Stone, W. L. (2023) · Antioxidants · doi:10.3390/antiox12061139 · Cited by 36
“Encouragingly, there is evidence showing that a low-calorie diet combined with long-term weight-loss support has the potential to reverse T2D in adults [21,22].”
BackgroundTargeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes
Zeppa, S. D., Gervasi, M., Bartolacci, A., Ferrini, F., Patti, A., Sestili, P., Stocchi, V., & Agostini, D. (2024) · Nutrients · doi:10.3390/nu16223951 · Cited by 35
“…there is evidence that extensive behavioral support can increase the durability of weight reduction with VLCD, people who do not receive the best possible assistance for sustained behavior change will still find it difficult to successfully adhere to these dietary methods over the long term [103].”
Jayedi, A., Zeraattalab-Motlagh, S., Shahinfar, H., Gregg, E. W., & Shab‐Bidar, S. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.03.018 · Cited by 39
Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment
Sannidhi, D., Abeles, R., Andrew, W., Bonnet, J. P., Vitale, K., Niranjan, V., Gulati, M., Pauly, K., Moran, R., Alexander, L., et al. (2025) · Nutrients · doi:10.3390/nu17142382 · Cited by 29
“May induce diabetes remission [198,199].”
Medical nutrition therapy for the management of type 2 diabetes mellitus
Barrea, L., Verde, L., Colao, A., Mandarino, L. J., & Muscogiuri, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01161-5 · Cited by 32
Soares, D. B. D. S., Shinjo, S. K., Santos, A. S., de Jesus, J. D. C. R., Schenk, S., de Castro, G. S., Zanoteli, E., Krustrup, P., da Silva, M. E. R., & de Sousa, M. V. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111831 · Cited by 18
Scores for Predicting Diabetes Remission in Bariatric Surgery: a Systematic Review and Meta-analysis
Sesconetto, L. D. A., da Silva, R. B. R., Galletti, R. P., Agareno, G. A., Colonno, B. B., de Sousa, J. H. B., & Tustumi, F. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06382-5 · Cited by 17
“Patients should be followed by a qualified nutrition team to guarantee a continued hypocaloric diet, increasing the chance for T2DM remission [23].”
BackgroundZhu, R., Fogelholm, M., Jalo, E., Poppitt, S. D., Silvestre, M. P., Møller, G., Huttunen‐Lenz, M., Stratton, G., Sundvall, J., Macdonald, I. A., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.02.002 · Cited by 17
Effects of a 3-Week Hospital-Controlled Very-Low-Calorie Diet in Severely Obese Patients
Ožvald, I., Božičević, D., Duh, L., Vrček, I. V., Pavičić, I., Domijan, A., & Milić, M. (2021) · Nutrients · doi:10.3390/nu13124468 · Cited by 11
Correia, V. P., Maria, B., Paulino, A., Ferreira, C. N., Gomes, O. C., Nogueira, F., Chiado, A., Coutinho, J., Marinho, R. T., & Miranda, L. G. (2023) · Surgical Endoscopy · doi:10.1007/s00464-023-09982-z · Cited by 10
“Although there is no standard dieting protocol after ESG, most centers follow a similar phased approach of variable duration that starts as a very low-calorie diet, broadly defined as consumption of fewer than 800 kcal per day, that quickly produces weight loss results and may even induce short-term onset of type 2 di…”
BackgroundEffect of d ‐β‐Hydroxybutyrate‐(R)‐1,3 Butanediol on Appetite Regulation in People with Prediabetes
Liu, Y., Bharmal, S. H., Kimita, W., & Petrov, M. S. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200615 · Cited by 8
Saiyalam, C., Shantavasinkul, P. C., Chirnaksorn, S., Rattanakaemakorn, P., Taonam, N., Rodphech, V., Putadechakum, S., Rattanasiri, S., Sirivarasai, J., Ongphiphadhanakul, B., et al. (2024) · Nutrients · doi:10.3390/nu16152407 · Cited by 8
“Our findings confirm those of previous studies, which have indicated that the predictors of T2D remission after either VLCD or MBS are a short duration of T2D, not currently taking insulin and a higher C -peptide level [48,49].”
ResultGlycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes
Vázquez, L. A., Romera, I., Santos, M. R., & Escalada, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01467-5 · Cited by 8
“Very-low-calorie diets can result in rapid weight loss and major improvements to glycaemic control and remission, but currently they are usually reserved for individuals with higher obesity degree (BMI [ 35 kg/ m 2 ) [28].”
BackgroundMozaffari, H., Civi, R. M., Askari, M., Lee, C., Wong, E., Wong, C., & Conklin, A. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103096 · Cited by 9
The Goldilocks for chronic weight management—Balancing quantity with quality of weight loss
Henriksen, K., Chakravarthy, M. V., Bager, C. L., Larsen, A. T., Mohamed, K. E., & Karsdal, M. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16379 · Cited by 4
Cho, E., Kim, S., Kim, H. J., Cho, B., Park, J., Kwon, H., Kim, J. Y., Go, Y., Kang, D. G., Shin, E., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1370737 · Cited by 6
“Very-low-calorie diets (VLCDs, 900 kcal/day) (6) using total diet replacements such as soups and shakes have proven beneficial for weight loss and diabetes remission for at least 2 years among people with obesity and type 2 diabetes (7, 8).”
BackgroundResultRecent progress of remission in type 2 diabetes
Zhao, Z., Yue, H., Zhang, X., Chen, F., Xu, J., & Shao, S. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251408210 · Cited by 4
“18 Currently, the dietary intervention methods mainly include low-carbohydrate diet, 25–28 ketogenic diet, 29–32 Mediterranean diet, 15,33,34 and intermittent fasting, 35–37 which have been summarized in Table 2.”
Bariatric Surgery in the Era of GLP1RA: A Narrative Review
Muhundan, M., & Dash, S. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03494-7 · Cited by 2
“Very low-calorie diets can lead to significant weight loss of 10–15% with remission of T2D, but subsequently weight gain is seen in most patients with recurrence of T2D [20].”
Personalized Medical Nutrition Therapy and Physical Exercise: The Future of Diabesity Care
Verde, L., Annunziata, G., Camajani, E., Tarsitano, M. G., Savastano, S., Colao, A., Muscogiuri, G., Caprio, M., & Barrea, L. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00688-6 · Cited by 5
“In patients with obesity and with recently diagnosed T2DM, LEDs and VLEDs have been shown to induce rapid weight loss of 10–15% or more, frequently leading to T2DM remission when implemented early in the disease course [11].”
InfluentialAshtekar, S. V., Deshmukh, P. P., Ghaisas, N., Ashtekar, C., Upasani, S., Kirloskar, M., Kumthekar, A., Kelkar, M. B., Ashtekar, R. S., Misar, P., et al. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_248_22 · Cited by 4
“The energy intakes of 1150 (F) and 1430 (M) at enrollment of 2‐OMEX subjects are not very low caloric diets as practiced in many remission trials.[7,19] This factor of modest reduction of intakes observed in our study favors sustainability of the campaign.”
BackgroundModelling remission from overweight type 2 diabetes reveals how altering advice may counter relapse
Sweatman, C. Z. W. H. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109180 · Cited by 2
Remission of Type 2 Diabetes: How, When, and for Whom?
Salis, S. S., Anjana, R. M., Unnikrishnan, R., Syed, S., & Mohan, V. (2022) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0078 · Cited by 4
Metabolism and Target Organ Damage
Fearon, N. M., & Pournaras, D. J. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.12 · Cited by 3
Hickson, K. A., Heppenstall, C., Treweeke, A. T., Coghill, E. M., Megson, I. L., Nicolson, S., Macfarlane, D. P., & MacRury, S. M. (2025) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.70128 · Cited by 1
Glutathione at the Crossroads of Redox Homeostasis and Glucose Metabolism in Diabetes Mellitus
Alom, S., Ali, F., Nongkhlaw, F. T., Bhutia, Y. D., & Kakoti, B. B. (2026) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-026-01409-5 · Cited by 1
Ashtekar, S. V., Ashtekar, R. S., Deshmukh, P. R., & Powar, J. D. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_795_23 · Cited by 1
“[24] Restriction of calorie intake has shown strong links with remission.”
BackgroundClarifications and Concerns Regarding the Therapeutic Fasting in Type 2 Diabetes Mellitus Patients
Vijayakumar, V., & Maheshkumar, K. (2024) · Journal of Health and Allied Sciences NU · doi:10.1055/s-0044-1787714
Suleiman, M., Yi, X., Bosi, E., Burdet, F., Luca, C. D., Tesi, M., Guerra, S. D., Pocai, A., SIMONE, P. D., Boggi, U., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-871924/v1
“Remission of T2D after caloric restriction or bariatric surgery has been reported to be less likely in subjects with increased duration of the disease (8-10,40).”
BackgroundPerilaku Diet di Kalangan Remaja
Syarifullah, M., & Pranata, R. (2024) · Jurnal Pendidikan Kesehatan Rekreasi · doi:10.59672/jpkr.v10i1.3415
Nutrition counsellors’ recommended eating patterns for individuals with type 2 diabetes in the USA
KHOSROVANEH, K. L., Hisamatsu, R., Reiss, J., RAU, J., Oshman, L. D., Diez, H. L., Lee, J. M., Aikens, J. E., Richardson, C. R., & Hafez, D. (2024) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2023-000845 · Cited by 1
Traitement de l’obésité : approches nutritionnelles atypiques et alternatives
Schlienger, J.-L. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.11.010 · Cited by 1
Gitton-Quent, O., Sola, M., Maziers, N., Hiol, A. N., Dechamp, N., Chatelier, E. L., Touvier, M., Galan, P., David, A., Morabito, C., et al. (2025) · Gut Microbes Reports · doi:10.1080/29933935.2025.2527766 · Cited by 1
Design of an explainable back propagation neural network for diabetes prediction
Ghosh, A., Saha, S., & Sarkar, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26747-5.00002-1
AlShammari, A. A., & AlSahow, A. (2025) · World Journal of Nephrology · doi:10.5527/wjn.v14.i4.109875
Jebarani, S., Bhavadharini, B., Baskar, V., Bhuvaneshwari, R., Rani, C. S. S., Lavonya, A., Ganesan, S., Akshay, A. S., Acharyya, M., Routray, P., et al. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01858-4
“However, weight regain is a key factor in relapse, with up to 25% of individuals relapsing within 2 years despite initial success [10, 31].”
Abedalqader, T., Strathman, A. R., Migliorini, A., Cerecedo, L. G., Ghazal, N. E., Yang, W., Dan, A., Mundi, M. S., & Ghanem, O. M. (2026) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/7371866
“Factors such as disease duration and patient age were found to infuence the likelihood of glycemic remission [48, 50, 52].”
InfluentialLiu, Q., Breen, S., Men, M., & HOCKING, S. L. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113559
Kale, M. C., Purandare, V. B., Tiwari, S., Aherkar, J., Kulkarni, G., Manekar, S., & Unnikrishnan, A. (2026) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2026.103487
Mechanisms of Hepatic Insulin Resistance and Its Contribution to the Pathogenesis of Type 2 Diabetes
Onyango, A. N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70285
Metadata
- Authors
- Juray, S., Axen, K. V., & Trasino, S. E.
- Affiliations
- Mount Sinai Hospital (US)
- City University of New York (US)
- Corresponding author
- Trasino, Steven E.
- ORCID
- Trasino, Steven E.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-06-18
- Volume
- 13
- Issue
- 6
- Pages
- 2086
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8234895
- OpenAlex
- W3175270726
- Cited by
- 45
- References
- 80
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 14 · 2023: 6 · 2022: 7 · 2021: 2
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CUNY Academic Works (City University of New York) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- type 2 diabetes remission, very low calorie diet, hypocaloric diet, weight loss, glycemic control
- MeSH terms
- Body Weight, Energy Intake, Diabetes Mellitus, Type 2, Humans, Obesity, Weight Loss, Caloric Restriction, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.